Modifies provisions relating to alternative therapies and treatments, including psilocybin

HB 1643 legalizes limited personal use of psilocybin (a compound found in "magic mushrooms") for therapeutic purposes under strict conditions. It directly affects adults aged 21+ with qualifying conditions like end-of-life care, PTSD, major depression, or substance use disorders, as documented by a physician. Key provisions require users to obtain medical documentation, use a trained facilitator (with specific qualifications), undergo lab testing, and limit intake to 150mg annually. The bill also shields facilitators, healthcare providers, and labs from legal penalties for compliant use, while maintaining patient confidentiality.